Fusion protein comprising angiopoietin receptor-binding and a multimerization domain
CA 2486649 C · Owner: Aprogen Inc. · Inventors: Koh, Gou Young
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present application describes fusion proteins that includes coiled coil domain capable of forming dimers or multimers in particular that coiled coil , domain from GCN4 cartilage matrix protein, cartilage oligomeric matrix protein or matrilin, fused to a further domain in particular those derived , from angiopoietin an ephrin, thrombospondin, VEGF, EGF, PDGF FGF, NGF, erythropoietin, an interleukin or RANKL.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 21, 2003 and granted August 5, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 21, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 21, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.